We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.93%
AUM
$8.36B
AUM Growth
+$811M
Cap. Flow
+$508M
Cap. Flow %
6.08%
Top 10 Hldgs %
9.6%
Holding
2,400
New
686
Increased
686
Reduced
568
Closed
456
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.59%
2 Technology 14.57%
3 Financials 13%
4 Industrials 11.45%
5 Healthcare 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EMKR icon
1826
DELISTED
Emcore
EMKR
$152K ﹤0.01%
+3,204
New +$156K
2018 Q3
0 quarters
FRBK
1827
DELISTED
Republic First Bancorp
FRBK
$151K ﹤0.01%
21,092
-3,113
-13% -$23.7K
2018 Q2
1 quarter
AVP
1828
DELISTED
Avon Products
AVP
$151K ﹤0.01%
68,500
-575,463
-89% -$1.06M
2017 Q2
5 quarters
RIGL icon
1829
Rigel Pharmaceuticals
RIGL
$755M
$150K ﹤0.01%
4,659
-4,323
-48% -$130K
2018 Q2
1 quarter
MACK icon
1830
DELISTED
Merrimack Pharmaceuticals
MACK
$150K ﹤0.01%
35,697
+20,092
+129% +$84.7K
2018 Q2
1 quarter
BW icon
1831
Babcock & Wilcox
BW
$515M
$148K ﹤0.01%
14,397
+10,428
+263% +$173K
2018 Q2
1 quarter
CLSD icon
1832
DELISTED
Clearside Biomedical
CLSD
$147K ﹤0.01%
1,597
+780
+95% +$92.7K
2018 Q2
1 quarter
PLAB icon
1833
Photronics
PLAB
$1.42B
$147K ﹤0.01%
14,920
-66,535
-82% -$618K
2017 Q3
4 quarters
GCI icon
1834
DELISTED
Gannett
GCI
$147K ﹤0.01%
14,726
-16,587
-53% -$170K
2018 Q2
1 quarter
VNET icon
1835
VNET Group
VNET
$622M
$146K ﹤0.01%
+14,502
New +$142K
2018 Q3
0 quarters
JNCE
1836
DELISTED
Jounce Therapeutics
JNCE
$146K ﹤0.01%
+22,509
New +$167K
2018 Q3
0 quarters
LOMA icon
1837
Loma Negra
LOMA
$925M
$144K ﹤0.01%
+16,268
New +$155K
2018 Q3
0 quarters
BKS
1838
DELISTED
Barnes & Noble
BKS
$144K ﹤0.01%
+24,748
New +$140K
2018 Q3
0 quarters
OPCH icon
1839
Option Care Health
OPCH
$4.73B
$143K ﹤0.01%
+11,522
New +$135K
2018 Q3
0 quarters
BTAI icon
1840
DELISTED
BioXcel Therapeutics
BTAI
$142K ﹤0.01%
+1,156
New +$172K
2018 Q3
0 quarters
ASC icon
1841
Ardmore Shipping
ASC
$698M
$140K ﹤0.01%
+21,524
New +$152K
2018 Q3
0 quarters
CVE icon
1842
Cenovus Energy
CVE
$48.9B
$138K ﹤0.01%
13,802
-73,040
-84% -$713K
2018 Q2
1 quarter
VIAV icon
1843
Viavi Solutions
VIAV
$6.57B
$137K ﹤0.01%
12,048
-6,686
-36% -$72.2K
2017 Q4
3 quarters
SOS icon
1844
SOS
SOS
$3.87M
– –
0
– –
2018 Q1
2 quarters
SFE
1845
DELISTED
Safeguard Scientifics
SFE
$135K ﹤0.01%
14,470
+3,249
+29% +$35.3K
2018 Q2
1 quarter
ORN icon
1846
Orion Group Holdings
ORN
$276M
$134K ﹤0.01%
17,755
-18,796
-51% -$162K
2017 Q3
4 quarters
FRO icon
1847
Frontline
FRO
$10.1B
$131K ﹤0.01%
22,494
-10,933
-33% -$57.7K
2017 Q4
3 quarters
UGP icon
1848
Ultrapar
UGP
$5.43B
$130K ﹤0.01%
+28,128
New +$150K
2018 Q3
0 quarters
VWTR
1849
DELISTED
Vidler Water Resources
VWTR
$128K ﹤0.01%
10,211
-27,064
-73% -$333K
2018 Q2
1 quarter
ENT
1850
DELISTED
Global Eagle Entertainment
ENT
$128K ﹤0.01%
1,816
+928
+105% +$59.8K
2018 Q2
1 quarter

Similar funds

Squarepoint's Q3 2018 Portfolio in Review

As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Squarepoint deployed $508M of net new capital in Q3 2018, opening 686 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.

  • Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
  • Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
  • Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
  • Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
  • Squarepoint opened 686 new positions and closed 456 in Q3 2018.
  • Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.